- Home
- XBIT vs OXSQ Comparison
XBIT vs OXSQ Comparison
Compare XBIT & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XBIT | OXSQ |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.5M | 144.4M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | XBIT | OXSQ |
|---|---|---|
| Price | $2.40 | $1.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 73.6K | ★ 641.5K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 22.70% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $40,142,565.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.09 | $1.56 |
| 52 Week High | $7.24 | $2.87 |
Technical Indicators
Market Signals| Indicator | XBIT | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 50.19 |
| Support Level | $2.15 | $1.82 |
| Resistance Level | $2.65 | $1.87 |
| Average True Range (ATR) | 0.15 | 0.03 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 33.33 | 75.00 |
Price Performance
Historical ComparisonAbout XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.